Single‐agent bevacizumab in the treatment of recurrent or refractory pediatric low‐grade glioma: A single institutional experience

Pediatric Blood &Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2GiIWi4
via IFTTT